326 related articles for article (PubMed ID: 20965168)
1. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury.
Sauerbeck A; Gao J; Readnower R; Liu M; Pauly JR; Bing G; Sullivan PG
Exp Neurol; 2011 Jan; 227(1):128-35. PubMed ID: 20965168
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors.
Semple BD; Noble-Haeusslein LJ
Exp Neurol; 2011 Jun; 229(2):195-7. PubMed ID: 21316363
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery.
Patel SP; Cox DH; Gollihue JL; Bailey WM; Geldenhuys WJ; Gensel JC; Sullivan PG; Rabchevsky AG
Exp Neurol; 2017 Jul; 293():74-82. PubMed ID: 28365473
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-γ agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats.
Lan LF; Zheng L; Yang X; Ji XT; Fan YH; Zeng JS
CNS Neurosci Ther; 2015 May; 21(5):410-6. PubMed ID: 25611692
[TBL] [Abstract][Full Text] [Related]
5. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor.
d'Avila JC; Lam TI; Bingham D; Shi J; Won SJ; Kauppinen TM; Massa S; Liu J; Swanson RA
J Neuroinflammation; 2012 Feb; 9():31. PubMed ID: 22335939
[TBL] [Abstract][Full Text] [Related]
6. Calcium Channel Blockade and Peroxisome Proliferator Activated Receptor γ Agonism Diminish Cognitive Loss and Preserve Endothelial Function During Diabetes Mellitus.
Jain S; Sharma BM; Sharma B
Curr Neurovasc Res; 2016; 13(1):33-44. PubMed ID: 26648342
[TBL] [Abstract][Full Text] [Related]
7. A single dose of PPARγ agonist pioglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats.
Pilipović K; Župan Ž; Dolenec P; Mršić-Pelčić J; Župan G
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():8-20. PubMed ID: 25579788
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis.
Aghaei I; Shabani M; Doustar N; Nazeri M; Dehpour A
Pharmacol Biochem Behav; 2014 May; 120():133-9. PubMed ID: 24631483
[TBL] [Abstract][Full Text] [Related]
9. PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.
Jiang LY; Tang SS; Wang XY; Liu LP; Long Y; Hu M; Liao MX; Ding QL; Hu W; Li JC; Hong H
CNS Neurosci Ther; 2012 Aug; 18(8):659-66. PubMed ID: 22620268
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats.
Liu H; Rose ME; Culver S; Ma X; Dixon CE; Graham SH
Biochem Biophys Res Commun; 2016 Apr; 472(4):648-55. PubMed ID: 26947332
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of donepezil attenuates the efficacy of environmental enrichment on neurobehavioral outcome after experimental traumatic brain injury.
Bondi CO; Yelleswarapu NK; Day-Cooney J; Memarzadeh K; Folweiler KA; Bou-Abboud CE; Leary JB; Cheng JP; Tehranian-DePasquale R; Kline AE
Restor Neurol Neurosci; 2018; 36(1):45-57. PubMed ID: 29439368
[TBL] [Abstract][Full Text] [Related]
12. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
[TBL] [Abstract][Full Text] [Related]
13. The novel compound LOE 908 attenuates acute neuromotor dysfunction but not cognitive impairment or cortical tissue loss following traumatic brain injury in rats.
Cheney JA; Brown AL; Bareyre FM; Russ AB; Weisser JD; Ensinger HA; Leusch A; Raghupathi R; Saatman KE
J Neurotrauma; 2000 Jan; 17(1):83-91. PubMed ID: 10674760
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex.
Ghavimi H; Charkhpour M; Ghasemi S; Mesgari M; Hamishehkar H; Hassanzadeh K; Arami S; Hassanzadeh K
Pharmacol Rep; 2015 Feb; 67(1):78-84. PubMed ID: 25560579
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone reduces secondary brain damage after experimental brain trauma by PPAR-γ-independent mechanisms.
Thal SC; Heinemann M; Luh C; Pieter D; Werner C; Engelhard K
J Neurotrauma; 2011 Jun; 28(6):983-93. PubMed ID: 21501066
[TBL] [Abstract][Full Text] [Related]
16. The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury.
McTigue DM; Tripathi R; Wei P; Lash AT
Exp Neurol; 2007 Jun; 205(2):396-406. PubMed ID: 17433295
[TBL] [Abstract][Full Text] [Related]
17. Morris water maze function and histologic characterization of two age-at-injury experimental models of controlled cortical impact in the immature rat.
Adelson PD; Fellows-Mayle W; Kochanek PM; Dixon CE
Childs Nerv Syst; 2013 Jan; 29(1):43-53. PubMed ID: 23089934
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal Rats.
Yeh JH; Wang KC; Kaizaki A; Lee JW; Wei HC; Tucci MA; Ojeda NB; Fan LW; Tien LT
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208374
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact.
Kline AE; Massucci JL; Marion DW; Dixon CE
J Neurotrauma; 2002 Apr; 19(4):415-25. PubMed ID: 11990348
[TBL] [Abstract][Full Text] [Related]
20. Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury.
Yonutas HM; Hubbard WB; Pandya JD; Vekaria HJ; Geldenhuys WJ; Sullivan PG
Exp Neurol; 2020 May; 327():113243. PubMed ID: 32057797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
